NFP
BIIB icon

Novak Financial Planning’s Biogen BIIB Stock Holding History

Novak Financial Planning’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$202K Buy
+584
New +$177K 0.1% 118

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Novak Financial Planning's BIIB Position: Q2 2021 in Review

Novak Financial Planning opened a new position in Biogen (BIIB) in Q2 2021: 584 shares worth $202K. The stake represents 0.1% of the portfolio and ranks #118 among its holdings.

1,104 funds tracked by Wall St. Rank hold BIIB as of Q2 2021.

  • Novak Financial Planning held 584 shares of Biogen worth $202K as of Q2 2021.
  • Biogen was a new Novak Financial Planning position in Q2 2021.
  • Biogen made up 0.1% of Novak Financial Planning's portfolio in Q2 2021, its #118 holding.
  • 1,104 funds tracked by Wall St. Rank held Biogen as of Q2 2021.

Based on Novak Financial Planning's 13F filing for Q2 2021, filed 21 Jul 2021.